Why Edwards Lifesciences Corp. Shares Soared

See why Medtronic's pain is Edwards Lifesciences gain.

Apr 14, 2014 at 1:40PM

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Edwards Lifesciences (NYSE:EW), a developer of surgical heart valve therapy products, today rocketed higher by as much as 16% after a federal judge in Delaware on Friday granted a preliminary injunction to limit sales of Medtronic's (NYSE:MDT) CoreValve system in the U.S. beginning in seven business days.

So what: According to the press release from Edwards Lifesciences, this ruling relates to a federal jury decision four years ago that CoreValue infringed upon Edwards' U.S. Andersen transcatheter aortic valve replacement patent. The judge also decreed that both Edwards and Medtronic should confer to determine in which instances CoreValve can still be used. As should come as no surprise, Medtronic plans to appeal the court's decision. In response to the late-Friday ruling, JPMorgan Chase upgraded Edwards to neutral from underweight and lifted its price target to $78 from $60. The bank also downgraded Medtronic to neutral and lowered its price target to $64.

Now what: This is certainly positive news for Edwards Lifesciences shareholders considering that the company's top-line growth has been stuck around 5% for some time now, and it could lead to increased sales of Edwards' Sapien valves. Of course, shareholders of either company will want to keep in mind that this is merely an injunction within the U.S., so CoreValve system sales won't be affected in foreign markets. With regard to valuation, given that aforementioned middling growth rate, Edwards' forward P/E of 24 might be a bit excessive even with an aging baby boomer population. For now I'm perfectly happy remaining on the sidelines and watching this situation play out.

Edwards Lifescience shares are soaring today, but even it could have a hard time keeping pace with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool owns shares of JPMorgan Chase and Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers